Anxiety, Depression, and Health-Related QOL in Patients Diagnosed with PAH or CTEPH
- 9 October 2017
- journal article
- pulmonary vascular-disease
- Published by Springer Nature in Lung
- Vol. 195 (6) , 759-768
Abstract
Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are life-threatening diseases with a high burden of symptoms. Although depression, anxiety, and reduced health related quality of life (HRQOL) have also been reported, a comparative analysis which explores these traits and their underlying factors was lacking.Keywords
This publication has 63 references indexed in Scilit:
- Pulmonary Hypertension in Portugal: First Data from a Nationwide RegistryBioMed Research International, 2013
- Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionRespiratory Research, 2013
- Psychometric performance of the CAMPHOR and SF-36 in pulmonary hypertensionBMC Pulmonary Medicine, 2013
- Rechtsherzkatheter-Untersuchung bei pulmonaler HypertonieDMW - Deutsche Medizinische Wochenschrift, 2011
- Developing Pulmonary Vasculopathy in Systemic Sclerosis, Detected with Non-Invasive Cardiopulmonary Exercise TestingPLOS ONE, 2010
- Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)European Heart Journal, 2009
- The multiple dimensions of dyspnea: Review and hypothesesRespiratory Physiology & Neurobiology, 2009
- Anxiety and Depression in COPDChest, 2008
- Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertensionEuropean Respiratory Journal, 2007
- Measurement of quality of life in pulmonary hypertension and its significanceEuropean Respiratory Journal, 2006